TB State-of-the-Art: Implications for Africa - Dereck Tait

INTEREST 2020

What you Need to Know about Public-Health Licensing and Access to Medicines in Africa - Sébastien Morin

INTEREST 2020

Using A Quality Improvement Collaborative Approach to Improve Tuberculosis Prevention Therapy Coverage in The Kavango Region, Namibia - Apollo Basenero

INTEREST 2020

Current Approaches for Identifying and Managing HIV Treatment Failure Among Children, Adolescents, and Young People In Sub- Saharan Africa: Multi-Country Experience from the New Horizons Collaborative - Natella Rakhmanina

INTEREST 2020

Prevalence, Risk and Protective Factors for Common Mental Disorders Among Young People Living With HIV Compared to Their Uninfected Peers From the Kenyan Coast: A Cross Sectional Study - Moses Kachama Nyongesa

INTEREST 2020

Syndemic of Hepatitis B and C and Their Coinfection With HIV in Rwanda: Role of Unsafe Medical Practices and Sexual Behaviors - Jean Damascene

INTEREST 2020

Trends in Transmitted Drug Resistance in A Cohort Of ART-Naive HIV- 1 Infected Individuals in Ethiopia - Mulugeta Kiros

INTEREST 2020

Patient-Reported Outcomes After Direct-Acting Antiviral Treatment for Chronic Hepatitis C in West And Central Africa: The ANRS 12311 TAC Trial - Fabienne Marcellin

INTEREST 2020

For Each Hour a Patient Living with HIV Spends in the Health Facility, the Probability of Being Retained in Care Decreases: Results from a Patients’ Satisfaction Survey in Mozambique - Caroline De Schacht

INTEREST 2020

Does Navigated Linkage to Care Work? A Cross-Sectional Study of Active Linkage to Care Within an Integrated Non-Communicable Disease - Kathryn Hopkins

INTEREST 2020

Q&A - Symposium 4 - ViiV - The ART of Paediatric HIV: An African Perspective

INTEREST 2020

Symposium 4 - ViiV - The ART of Paediatric HIV: An African Perspective

INTEREST 2020

Effect of Same-Day ART Initiation on Early Retention in Rakai, Uganda - Jesca Basiima

INTEREST 2020

Rapid Antiretroviral Therapy Initiation and the Risk of Mortality and Loss to Follow-Up in Children with HIV - Peter James Elyanu

INTEREST 2020

Q&A - Oral Abstract Presentations 2

INTEREST 2020

Getting to the Heart of Stigma: What does it take to have an impact at scale? - IAS

INTEREST 2020

High Levels of HIV Drug Resistance in Adult Patients with Unsuppressed Viral Load, Measured Through Routine Viral Load Programme Monitoring in South Africa, 2019 - Gillian Hunt

INTEREST 2020

Monitoring and Management of Treatment Failure Among People on Antiretroviral Therapy in Mozambique: Lessons Learned to Improve Treatment Effectiveness - Laura Marcela Torres

INTEREST 2020

Q&A - Symposium 3 - AbbVie - Evolving HIV Clinical Pathway: Approaches to Combine Rapidly Changing Guidelines and Sustainability of Anti-Retroviral Treatment in Resource Limited Settings

INTEREST 2020

Speaker 2 - Symposium 3 - AbbVie - Albert Mwango

INTEREST 2020

Speaker 1 - Symposium 3 - AbbVie - Jeremy Nel

INTEREST 2020

Stakeholder Participation in The Establishment of One-Stop Shops and Key Population-Friendly Facilities: Descriptive Lessons from the FHI 360 GF Project - Chidubem Oraelosi

INTEREST 2020

What shapes resilience among people living with HIV? A multi-country analysis of data from the PLHIV Stigma Index 2.0

INTEREST 2020

Cost-utility analysis of dolutegravir- versus efavirenz 400mg-based regimen for the initial treatment of HIV-infected patients in Cameroon: 96-week results from the NAMSAL ANRS 12313 trial

INTEREST 2020